Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

S2529Referred to Committee

A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-07-30
Introduced
1
Cosponsors
S
ⓘ
Type

Sponsor

Jon Husted
Jon Husted
Republican · OH · Senator
Votes with party: 34.2% (319 recorded votes)

Full profile: /officials/H001104

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Margaret Wood Hassan (D-NH)Original· 2025-07-30

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2025-07-30

Source: Congress.gov

Committee Activity

Currently in

  • Senate Committee on Health, Education, Labor, and PensionsReferred To · 2025-07-30

Previously

  • Health, Education, Labor, and Pensions CommitteeReferred To · 2025-07-30

Plain-English Summary

The proposal would create clearer rules and timelines for how pharmaceutical companies can request to switch medications from prescription-only to over-the-counter status, making the approval process more predictable and transparent. This would help drug makers understand exactly what steps they need to follow and what information the FDA requires when seeking to make a medicine available without a doctor's prescription. Patients could potentially gain faster access to certain medications they could buy directly, while companies would have more certainty about the process and timeline for getting approval.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • S4634CONNECT Act
    Referred to Committee · 2026-05-21
  • SRES743A resolution supporting the designation of May 3 through May 9, 2026, as "Children's Mental Health Awareness Week".
    Referred to Committee · 2026-05-20
  • S4531Student Aid Fraud Oversight and Accountability Act of 2026
    Referred to Committee · 2026-05-14
  • S4459Expanding Appalachia’s Broadband Access Act
    Referred to Committee · 2026-04-30